Global Gastroretentive Drug Delivery Systems Outsourcing Market Trends and Future Outlook to 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Predicted Market Size Of The Gastroretentive Drug Delivery Systems Outsourcing Industry By 2029?
In recent years, the market size for outsourced gastroretentive drug delivery systems has seen significant growth. The market, which was valued at $1.39 billion in 2024, is projected to increase to $1.49 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The growth experienced during this historical period is linked to several factors including escalating occurrence of stomach and small intestine disorders, increased usage of drug delivery systems, a higher prevalence of gastric cancer, increased government initiatives, and a rise in hospital numbers.
The market size of gastroretentive drug delivery systems outsourcing is projected to experience significant expansion in the coming years, reaching an estimated value of $1.98 billion in 2029, indicating a compound annual growth rate (CAGR) of 7.4%. This projected growth during the forecast period can be linked to numerous factors such as the surging number of ambulatory centers, enhanced focus on patient compliance and convenience, a rising prevalence of chronic diseases, the expansion of personalized medicine and an increase in the elderly population. Key trends set to predominately feature in the forecast period include improvements in polymer science, techniques of formulation, bioadhesive processes, innovative polymers, modifiers for drug release, the creation of gastroretentive dosage forms, the incorporation of digital health technologies, intelligent gastroretentive systems, and focused drug delivery.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp
Which Factors Are Steering Growth In The Gastroretentive Drug Delivery Systems Outsourcing Market?
The surge in gastrointestinal disorders is projected to drive the growth of the gastroretentive drug delivery systems outsourcing market. These disorders encompass a broad spectrum of diseases that impact the digestive tract, including the stomach, liver, gallbladder, intestines, and pancreas. Factors such as an aging population, antibiotic use, infectious agents, changes in diet, stress and lifestyle factors, and obesity contribute to the increase in gastrointestinal disorders. The outsourcing of gastroretentive drug delivery systems offers pharmaceutical firms the necessary resources and proficiency to contend with the mounting burden of gastrointestinal disorders, ultimately enhancing patient results and quality of life. For instance, data from the American Cancer Society (ACS), a US-based health organization dedicated to eradicating cancer, showed that gastrointestinal cancers rose by 3.18% to 348,840 in January 2023 from 338,090 in 2021 in the US. Thus, the upswing in gastrointestinal disorders is stimulating the gastroretentive drug delivery systems outsourcing market.
Which Segment Accounts For The Largest Share In The Gastroretentive Drug Delivery Systems Outsourcing Market?
The gastroretentive drug delivery systems outsourcingmarket covered in this report is segmented –
1) By Type: Floating Systems; Bioadhesive Systems; Other Types
2) By Dosage Form: Tablets; Liquid; Microspheres; Capsule; Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD); Neurological Disorders; Other Applications
4) By End User: Pharmaceutical Companies; Contract Research Organizations (CROs); Other End Users
Subsegments:
1) Floating Systems: Single Unit Systems; Multiple Unit Systems
2) Bioadhesive Systems: Hydrogels; Mucoadhesive Polymers
3) Other Types: Magnetically Assisted Systems; High-Density Systems; Osmotic Systems
Which Long-Term Trends Will Play A Crucial Role In The Gastroretentive Drug Delivery Systems Outsourcing Market?
Prominent firms active in the gastroretentive drug delivery systems outsourcing industry are concentrating on the creation of ground-breaking products such as ready-to-fill (RTF) colon functional capsules. These innovations aim to boost drug delivery competence and convenience for patients. RTF colon functional capsules are essentially pre-produced, empty capsules devised to carry specially designed formulations or active components targeted at the colon. An example of this innovative approach is Evonik’s EUDRACAP colon functional capsules, which were launched in September 2024. Evonik is a German company recognised for its breakthroughs in drug delivery. These pioneering capsules, created for the targeted delivery of oral medications to the ileo-colonic region, are currently the first of their kind RTF alternatives on the market. They are primarily used for transferring delicate active components like live biotherapeutic products (LBPs). While currently available in a technical grade, a GMP-grade version is also under development. The EUDRACAP colon has simplified the oral drug development procedure and fast-tracked the time to market, marking a remarkable progress in gastroretentive drug delivery systems.
Who Are The Dominant Players In The Gastroretentive Drug Delivery Systems Outsourcing Market Today?
Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Evonik Industries AG, Alcon Inc., SGS SA, Lonza Group AG, FMC Corporation, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc., Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Ranbaxy Laboratories Limited, Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Assertio Therapeutics Inc., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.
Access The Complete Report Here:
What Regional Factors Are Accelerating Growth In The Gastroretentive Drug Delivery Systems Outsourcing Market?
North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15813&type=smp
Browse Through More Reports Similar to the Global Gastroretentive Drug Delivery Systems Outsourcing Market 2025, By The Business Research Company
Gastric Cancer Drugs Global Market 2025
https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market
Gastrointestinal Drug Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report
Nasal Drug Delivery Technology Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
